Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 0378-6322

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 0378-6322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure Less Than 140 Mmhg At Week 8 (Image 01)

This is a table or graph showing the baseline SBP (Systolic Blood Pressure) in mmHg with values ranging from 100 to 200. The text mentions the use of Hydrochlorothiazide 25mg and its dosage in relation to blood pressure. It also indicates a target of SBP<140 (mmHg).*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure Less Than 90 Mmhg At Week 8 (Image 02)

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure Less Than 130 Mmhg At Week 8 (Image 03)

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure Less Than 80 Mmhg At Week 8 (Image 04)

The text appears to be a list of medications and dosage information, along with blood pressure measurements in mmHg. It is possible that this information is part of a medical study or clinical trial. The medication names include Valsartan and Hydrochlorothiazide at varying dosage levels. The "DBP<80(mmHg)" indicates that the patients had a baseline diastolic blood pressure reading of less than 80 mmHg.*

FDA Label Image

Valsartan Structural Formula (Image 05)

FDA Label Image

Hydrochlorothiazide Structural Formula (Image 06)

FDA Label Image

Valsartan And Hydrochlorothiazide Tablets, Usp 80 mg/12.5 mg Bottle Label (Image 07)

Hydrochlorothiazide is a medication available in tablet form with a usual dosage as prescribed in the accompanying information. The medication should be kept out of reach of children and stored at a temperature of 20-25°C with protection from moisture and heat. This medication is manufactured by Mylan Pharmaceuticals in India and dispensed in a tight, light-resistant container with child-resistant closure. It is available in a packaging of 90 tablets with a unique identification code.*

FDA Label Image

Valsartan And Hydrochlorothiazide Tablets, Usp 160 mg/12.5 mg Bottle Label (Image 08)

This is a medication containing Valsartan and Hydrochlorothiazide. The label advises to keep it out of reach and sight of children and to keep it in a tight container with child-resistant closure as per USP. The manufacturer's information is provided as Mylan Pharmaceuticals Inc. and the medicine is of 160 12.5 mg strength. There is a code and lot number printed for identification purposes.*

FDA Label Image

Valsartan And Hydrochlorothiazide Tablets, Usp 160 mg/25 mg Bottle Label (Image 09)

This is a description of a pharmaceutical product composition containing Valsartan and Hydrochlorothiazide. It indicates the usual dosage, and gives instructions on storage, highlighting the need to protect the container from moisture and heat. The manufacturer is Mylan Pharmaceuticals Inc.*

FDA Label Image

Valsartan And Hydrochlorothiazide Tablets, Usp 320 mg/12.5 mg Bottle Label (Image 10)

Valsartan USP is a medication with a strength of 320mg. The usual dosage should be determined by consulting the prescribing information. It is important to keep this medication out of the reach of children and store it at a controlled room temperature. The manufacturer is Mylan Pharmaceuticals Inc and it has been made in India. The rest of the information provides batch and coding details.*

FDA Label Image

Valsartan And Hydrochlorothiazide Tablets, Usp 320 mg/25 mg Bottle Label (Image 11)

This is a description of a prescription drug called Valsartan which has a strength of 320mg NDGC, and a second drug called Hydrochlorothiazide with a strength of 2mg. The label also mentions the name of the pharmaceutical company, Mylan Pharmaceuticals Inc, and some information on dosage and packaging, including lot number, expiry date, and tablet count. The remaining text either appears to be incomplete or irrelevant, or contains errors and therefore cannot be used to provide a meaningful description.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.